Clinical Trials in Oconto Falls, United States
Locations / Oconto Falls, United States
Delta Trials records 53 clinical trials conducted in Oconto Falls, United States, making it a notable site of clinical research activity. These trials across 460 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Oconto Falls has changed over time.
53
Total Trials
460
Conditions
0
Terminated since 2020
Browse by condition (460 total)
- Malignant solid neoplasm 4 trialsAll Malignant solid neoplasm trials
- Recurrent ovarian carcinoma 4 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Ovarian seromucinous carcinoma 3 trialsAll Ovarian seromucinous carcinoma trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- All Clinical stage iv cutaneous melanoma ajcc v8 trials
- All Recurrent primary peritoneal carcinoma trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Acute myeloid leukemia 3 trialsAll Acute myeloid leukemia trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Clinical stage iii cutaneous melanoma ajcc v8 trials
- Recurrent endometrial carcinoma 3 trialsAll Recurrent endometrial carcinoma trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Recurrent fallopian tube endometrioid adenocarcinoma trials
- All Ann arbor stage iv diffuse large b-cell lymphoma trials